BioLumic's xTraits platform uses light to activate or suppress gene expression in seeds without chemical inputs or genetic modification. By harnessing photomorphogenesis as a natural biological switch ...
Initial focus on named-patient access in selected European and MENA markets, providing a capital-efficient foundation for broader commercialization ...
The recurrence of violations at multiple sites led the FDA to conclude that Baxter management must improve its oversight and control of manufacturing.
Company to host conference call and webcast on November 5, 2026, at 8:00 a.m. ET (9:00 p.m. HKT) SHANGHAI & CAMBRIDGE, Mass.- ...
RNA-Logix connects biological questions, experimental evidence, and RNA medicine design in a single investigative workflow.
Two New Patient Registries to Be Implemented on NORD's IAMRARE® Platform with support from the Critical Path Institute.
United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2026 financial results ...
(Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule ...
ProBio Inc., a global contract research, development and manufacturing organization (CRDMO), today announced the successful ...
Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced the acceptance of 12 ...
New research led by the University of Colorado Anschutz is offering hope to people living with stiff person syndrome (SPS), ...
Multi-center, randomized controlled study will evaluate the safety and preliminary efficacy of investigational injectable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results